CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.88
-1.30 (-2.23%)
At close: Dec 5, 2025, 4:00 PM EST
57.17
+0.29 (0.52%)
After-hours: Dec 5, 2025, 7:59 PM EST
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.42 billion as of December 5, 2025. Its market cap has increased by 34.27% in one year.
Market Cap
5.42B
Enterprise Value
3.69B
1-Year Change
34.27%
Ranking
Category
Stock Price
$56.88
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.42B, an increase of 867.81%. That is a compound annual growth rate of 28.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 5.54B | 65.04% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.09B |
| Johnson & Johnson | 487.35B |
| AbbVie | 400.38B |
| UnitedHealth Group | 299.62B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.73B |
| Merck & Co. | 248.38B |
| Abbott Laboratories | 217.85B |